Toll Free Phone & Fax
Welcome to Medsengage !
Chat Now
Need Help?
Have a Question?

Gemzar injection


(Gemcitabine)
Manufacturer: Eli Lilly
Formulation: Injection

Click here to
view generic equivalent to Gemzar injection

Generic Equivalent to Gemzar injection

Manufacturer: Not Manufactured By Eli Lilly
Formulation: Injection

Gemzar injection

PRESCRIPTION REQUIRED | BRAND NOT AVAILABLE

Alternate Brand Name: Gemzar, Gemcite

Gemzar is a cancer medicine that interferes with the growth and spread of cancer cells in the body.

Gemzar is used to treat cancers of the pancreas, lung, ovary, and breast.

Recommendation:.

The recommended dose of 1000 mg/m² intravenously one time over 30 minutes. May repeat at weekly intervals for up to 7 weeks, followed by one week of rest. If toxicity occurs, a dose should be held. Subsequent cycles should consist of weekly cycles for 3 consecutive weeks, out of every 4 weeks.

Gemzar can lower blood cells that help your body fight infections and help your blood to clot. You may get an infection or bleed more easily. Call your doctor if you have unusual bruising or bleeding, or signs of infection (fever, chills, body aches).

Gemzar can affect your liver, kidneys, or lungs. Tell your doctor if you have stomach pain, dark urine, yellow skin or eyes, little or no urinating, swelling, rapid weight gain, severe shortness of breath, wheezing, or cough with foamy mucus.

Precautions:

Avoid being near people who are sick or have infections. Tell your doctor at once if you develop signs of infection.

Avoid activities that may increase your risk of bleeding or injury. Use extra care to prevent bleeding while shaving or brushing your teeth.

Do not receive a "live" vaccine while using Gemzar, and avoid coming into contact with anyone who has recently received a live vaccine. There is a chance that the virus could be passed on to you. Live vaccines include measles, mumps, rubella (MMR), rotavirus, typhoid, yellow fever, varicella (chickenpox), zoster (shingles), and nasal flu (influenza) vaccine.

Breastfeeding:

There are no data on the excretion of gemcitabine into human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, the mother should be warned and a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother and the potential risk to the infant.

Active Ingredient: Gemcitabine

8 Item(s)

per page
Type
Product Name
Dosage
Quantity
Price
Action

8 Item(s)

per page

Important NoteNote: We are only able to ship a maximum 90-day supply of your prescription.

Pharmacist Consultation

pharmacist-consultaion